On August 24, GSK announced that its antisense oligonucleotide (ASO) drug Hibsago (bepirovirsen) had been approved by Japan’s Ministry of Health. For the functional cure
An Unmet Market Need: 788 million Patients, No Approved Antifibrotic Drug According to the GBD 2023 study, approximately 788 million adults aged 20 years and
October 21, 2026
No Comments
Newsletter
Sign up our newsletter to get update information, news and free insight.